个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共11条记录  
  • Cangrelor tetrasodium
    [作者:Diaz-Ricart, M; Escolar, G; Serradell, N; Rosa, E; Bolos, J,期刊:Drugs of the Future, 页码:101-110 , 文章类型: Article,,卷期:2008年33-2]
  • Cangrelor (AR-C69931MX) is a nonthienopyridine direct-acting P2Y(12) antagonist under development for the treatment of acute coronary syndrome and as an ultrafast-acting intravenous antithrombotic agent. Cangrelor inh...

  • BiTE: a new class of antibodies that recruit T-cells
    [作者:Baeuerle, PA; Reinhardt, C; Kufer, P,期刊:Drugs of the Future, 页码:137-147 , 文章类型: Review,,卷期:2008年33-2]
  • Certain bispecific antibodies hold promise for redirecting cytotoxic T-cells, the body's most effective killer cells, against malignant cells. This cannot be achieved by conventional monoclonal antibodies because T-ce...

  • Compounds for dementia from Hericium erinaceum
    [作者:Kawagishi, H; Zhuang, C,期刊:Drugs of the Future, 页码:149-155 , 文章类型: Review,,卷期:2008年33-2]
  • Our group has been conducting a search for compounds for dementia derived from medicinal mushrooms since 1991. A series of benzyl alcohol derivatives (named hericenones C to H), as well as a series of diterpenoid deri...

  • Systemic mastocytosis
    [作者:Jain, N; Verstovsek, S,期刊:Drugs of the Future, 页码:187-192 , 文章类型: Editorial Material,,卷期:2008年33-2]
  • Mastocytosis is a heterogeneous group of disorders characterized by clonal expansion of mast cells. Clinical course can range from no or minimal symptoms to diffuse systemic involvement with multiorgan failure. The di...